HCMC – Siemens Healthineers on September 10 released findings of a regional survey showing Vietnamese patients strongly support the use of digital technologies in cancer care, though screening rates remain low.
The study, titled “Bridging the Gaps: Public Perceptions of the Cancer Care Continuum in Southeast Asia” and conducted by YouGov, polled more than 6,000 people in six countries. The survey was conducted online from July 21 to 29.
In Vietnam, 84% of respondents said early detection is critical, but only 34% had undergone cancer screening and just 13% took specific tests. Among those who had not been screened, 35% said it was unnecessary, 22% cited high costs, and another 22% feared a diagnosis.
Traditional treatments such as radiation (47%), chemotherapy (44%) and surgery (33%) were better known than newer methods like personalized treatment (26%) and immunotherapy (16%). While 74% of respondents were aware of post-treatment care, nearly half admitted not knowing what it involves.
Support for innovation was strong, with 54% of Vietnamese respondents expecting technologies such as artificial intelligence, genetic testing and real-time monitoring to improve outcomes – the second-highest rate in Southeast Asia after the Philippines. Nearly half also favored integrated “one-stop” cancer care centers, where screening, treatment and follow-up services are provided in the same facility.
“There is a pressing need to view cancer care as a continuum – from screening and diagnosis to treatment and survivorship,” said Fabrice Leguet, Siemens Healthineers’ Southeast Asia president.
Siemens Healthineers operates in more than 70 countries with about 72,000 employees worldwide. The company focuses on medical imaging, laboratory diagnostics, cancer care and minimally invasive therapies, supported by digital and artificial intelligence solutions.
